Jupiter Neurosciences
Tracked across 3 events · 25 articles · First seen Jun 09, 2026 · Last active Aug 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jupiter Neurosciences is the licensee, gaining exclusive U.S. rights to ALA-002, expanding its CNS pipeline and potentially increasing its market value.
Jul 21, 2026 · 6 articles
Business
Impact: Jupiter Neurosciences is the company executing the reverse stock split to regain Nasdaq compliance. The split reduces share count but does not change market capitalization, and the low stock price reflects financial distress.
Aug 05, 2026 · 6 articles
Business
Impact: Jupiter Neurosciences is presenting at the 93rd Emerging Growth Conference to engage with investors and showcase its company, products, and services.
Jun 09, 2026 · 13 articles
ERGEN INTELLIGENCE
Track Jupiter Neurosciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard